U.S. Other Utilities Stock News

If you are wondering whether Hilton Worldwide Holdings at around US$303 per share offers fair value or is pricing in too much optimism, this breakdown will help you frame the stock through several valuation lenses. The share price closed at US$303.16, with returns of 2.9% over 7 days, a 2.8% decline over 30 days, 3.5% year to date, 29.4% over 1 year, 125.0% over 3 years and 154.0% over 5 years. This raises clear questions about what is already reflected in the price. Recent coverage has...

EDAP TMS (NasdaqGM:EDAP) has reported Q3 2025 revenue of €13.9 million, with a basic EPS loss of €0.13 and net income loss of €5.0 million, while the trailing twelve months show revenue of €63.8 million, basic EPS loss of €0.52 and a net income loss of €19.6 million. Over recent quarters, the company has reported revenue of €13.1 million in Q3 2024, €20.3 million in Q4 2024 and €16.0 million in Q2 2025. Quarterly EPS losses have ranged from €0.05 in Q4 2024 to €0.19 in Q1 2025. This...

Waterdrop (NYSE:WDH) has put solid numbers on the table for FY 2025 so far, with third quarter revenue of ¥974.9 million and basic EPS of ¥0.44, alongside trailing 12 month EPS of ¥1.40 supported by net income of ¥506.4 million on revenue of ¥3.25 billion. Over recent quarters the company has seen revenue move from ¥676.2 million in Q2 2024 to ¥753.7 million in Q1 2025 and then to ¥974.9 million in Q3 2025. Basic EPS progressed from ¥0.24 in Q2 2024 to ¥0.30 in Q1 2025 and ¥0.44 in Q3 2025,...

The U.S. FDA has issued a warning letter to ImmunityBio over allegedly false and misleading promotional claims for its bladder cancer drug Anktiva. The letter focuses on how Anktiva has been marketed to healthcare professionals and patients, and requests corrective action from the company. This regulatory action introduces additional marketing and compliance risk for ImmunityBio at a time when its drug portfolio is gaining wider attention. For investors following ImmunityBio, ticker...

Occidental Petroleum has completed the sale of its OxyChem chemical business for about US$9.70 billion, directing the proceeds toward debt reduction and sharpening its focus on core oil and gas operations. This portfolio shift, alongside planned 2026 capital investment of US$5.50 billion to US$5.90 billion, marks a meaningful rebalancing of the company toward its highest-priority energy assets. Next, we’ll examine how this OxyChem divestment and debt reduction effort could reshape Occidental...

Formula One Group (FWON.K) is facing fresh scrutiny after canceling its Bahrain and Saudi Arabia grands prix because of escalating conflict in the Middle East, removing two high-fee races from its current calendar. See our latest analysis for Formula One Group. The recent cancellations come at a time when Formula One Group’s share price has a 90 day share price return of a 14% decline and a year to date share price return of a 15% decline. Meanwhile, the 5 year total shareholder return of 99%...

If you are wondering whether Danaher at around US$187 per share is starting to look appealing, or if the market still has it priced richly, this breakdown will help you frame that question clearly. The stock has recently been under pressure, with returns of a 2.3% decline over 7 days, 11.3% decline over 30 days, 18.8% decline year to date, and 10.5% decline over 1 year, which can change how investors think about both upside potential and risk. Recent coverage has focused on Danaher in the...

Wondering whether Euronet Worldwide at a last close of US$67.11 still reflects its true worth, or if the market is mispricing the stock. The share price has been under pressure, with returns of a 0.8% decline over 7 days, a 4.8% decline over 30 days, a 9.4% decline year to date, and a 38.8% decline over the past year, adding to an already weak 3-year and 5-year picture of 38.5% and 51.5% declines. Recent news coverage has focused on Euronet Worldwide's position within the Diversified...

ParkerVision has completed appellate briefing in its patent infringement case against QUALCOMM, challenging a key non infringement argument. The appeal highlights an alleged contradiction in QUALCOMM’s technical position, placing added focus on a prior legal ruling. This development brings renewed attention to QUALCOMM’s legal exposure, an area that has received less coverage than capital returns, competition, and shareholder actions. For investors watching QUALCOMM, ticker NasdaqGS:QCOM,...

KB Home Q1 2026: Earnings slip as margins come under pressure KB Home (KBH) opened fiscal 2026 with Q1 revenue of US$1,077.0 million and basic EPS of US$0.53, alongside net income of US$33.4 million as investors weigh how these figures fit into the broader housing cycle. Over recent quarters the company has seen quarterly revenue move from US$1,391.8 million in Q1 2025 to a peak of US$1,999.9 million in Q4 2024 before easing back to US$1,077.0 million in the latest quarter. Quarterly basic...

Lockheed Martin (NYSE:LMT) and the U.S. Department of Defense have entered into a major framework agreement to accelerate Precision Strike Missile production. The agreement is intended to expand U.S. missile manufacturing capacity to meet rising domestic and allied demand. The framework may support a multi year commitment, aligning with higher defense priorities and industrial mobilization efforts. For investors watching NYSE:LMT, this new PrSM framework sits against a backdrop of strong...

Wondering if Salesforce at around US$181.96 is starting to look like value or still pricing in too much optimism? This article breaks down what the numbers are really saying about the stock. The share price has recently moved, with a 6.4% decline over the last 7 days, a 2.1% gain over 30 days, and returns of 28.3% lower year to date and 34.8% lower over 1 year. This naturally raises questions about whether expectations have reset enough. Recent news coverage has centered on Salesforce's role...

LeMaitre Vascular (LMAT) has caught investor attention after its share price reached a recent close of $109.99, with returns over the past month and past 3 months standing out compared with its longer term record. See our latest analysis for LeMaitre Vascular. That recent move to a share price of $109.99 follows a 30.41% 3 month share price return and a 37.20% year to date share price return, alongside a 141.90% 5 year total shareholder return. Together, these figures indicate momentum...

Recent returns and current snapshot Medpace Holdings (MEDP) has delivered a 1 day return of 1.3% and about 2.6% over the past week, with a month gain of roughly 4.9% and a past 3 months return of 18.4%. Over longer horizons, total returns stand at about 47.0% for the past year, around 1.5x over three years, and roughly 1.8x over five years, against a recent close of US$466.80. See our latest analysis for Medpace Holdings. MEDP's recent share price moves, including a 4.9% 1 month share price...

DigitalOcean Holdings (NYSE:DOCN) has completed an $800 million follow-on equity offering. The capital raise is intended to fund infrastructure expansion, including its AI platform, and to strengthen the balance sheet. The offering adds fresh equity capital that management plans to direct toward cloud and AI capacity to support customer demand. For readers tracking NYSE:DOCN, this raise comes with the stock at a share price of $87.0 and a value score of 1. Recent returns have been strong,...

Earlier this week, Compass withdrew its lawsuit against Zillow after Zillow agreed to stop penalizing homes marketed first on Compass or Redfin websites, a shift the company describes as expanding marketing freedom for sellers and agents. Separately, Compass-affiliated team Irina Norrell & Co. launched an AI-built, 97-page regional education platform, underscoring how artificial intelligence is starting to empower small real estate teams with tools that previously required far greater...

In its latest reported quarter, Icahn Enterprises posted revenue growth of 5.9% year on year, beating analyst estimates by 10.4% but missing earnings expectations. This combination of stronger-than-forecast sales and weaker profitability has refocused attention on how effectively the conglomerate is converting its diversified operations into sustainable earnings. We’ll now examine how Icahn Enterprises’ revenue beat but earnings miss could influence the investment narrative around its...

Builders FirstSource, Inc. was recently removed from the FTSE All-World Index (USD), a major global equity benchmark that guides many index-tracking investment strategies. This index exclusion can meaningfully affect how both passive and active investors view Builders FirstSource’s role in diversified global equity portfolios. We’ll now examine how the company’s removal from the FTSE All-World Index might influence its investment narrative and long-term positioning. AI is about to change...

AECOM (NYSE:ACM) has extended its multi decade partnership with San Diego Unified School District. The company has been selected as prime consultant to support school modernization, safety, security, and sustainability upgrades. The new role covers projects such as new classrooms, safety and security initiatives, and sustainability improvements across the district. AECOM operates at the intersection of infrastructure, buildings, and environmental services, and this new prime consultant role...

Paysign (PAYS) has wrapped up FY 2025 with fourth quarter revenue of about US$22.8 million and basic EPS of US$0.02, set against trailing twelve month revenue of US$82.0 million and EPS of US$0.14 that follows reported earnings growth of 97.9% over the past year. The company has seen revenue move from US$56.5 million on a trailing basis in Q3 2024 to US$82.0 million by Q4 2025, while trailing EPS has shifted from US$0.15 to US$0.14. This sets up a story where investors are weighing 20.3%...

FuboTV Inc. completed a 1-for-12.00048 stock split on March 24, 2026, rebalancing its share count and per-share price structure. This unusually granular split ratio highlights management’s focus on aligning FuboTV’s capital structure with listing requirements and investor accessibility objectives. Next, we’ll examine how this unconventional stock split ratio could influence FuboTV’s investment narrative and appeal to different investor groups. We've uncovered the 12 dividend fortresses...

In March 2026, the University of Missouri announced a consulting agreement with Burns & McDonnell for its NextGen MURR research reactor, with BWX Technologies joining as a sub-contractor to support design, licensing and project oversight for this state-of-the-art nuclear medicine and research facility. This role further embeds BWX Technologies in the nuclear medical isotope supply chain, aligning its nuclear engineering capabilities with long-term cancer treatment and research demand backed...

Tempus AI and Daiichi Sankyo have entered into a collaboration to use Tempus' multimodal AI models in an oncology drug program. The partnership focuses on improving patient stratification and clinical development for an antibody drug conjugate. Tempus' real world oncology database and AI technology will be integrated directly into a late stage drug program. For investors tracking NasdaqGS:TEM, this agreement indicates that Tempus AI is operating increasingly as a platform partner to large...

Event context and recent performance SPX Technologies (SPXC) has drawn investor attention after recent share price moves, with the stock last closing at US$201.27 and showing mixed short term returns over the past week and month. See our latest analysis for SPX Technologies. That short term softness, including a 1 month share price return of 15.14% decline, sits alongside a much stronger long term picture. A 1 year total shareholder return of 47.91% suggests earlier optimism about growth or...